GALECTIN THERAPEUTICS INC. Income (Loss) from Equity Method Investments
GALECTIN THERAPEUTICS INC. (GALT) reported Income (Loss) from Equity Method Investments of $0 for the 3-month period ending 2016-03-31, per its 10-Q filed 2016-05-10.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2016-05-10
- GALECTIN THERAPEUTICS INC. income (loss) from equity method investments for the quarter ending 2016-03-31 was $0.00.
- GALECTIN THERAPEUTICS INC. income (loss) from equity method investments for the quarter ending 2015-03-31 was $0.00.
- GALECTIN THERAPEUTICS INC. income (loss) from equity method investments for the quarter ending 2014-12-31 was -$10.00K.
- GALECTIN THERAPEUTICS INC. income (loss) from equity method investments for the quarter ending 2014-09-30 was -$53.00K.
- GALECTIN THERAPEUTICS INC. income (loss) from equity method investments for fiscal 2014 was -$400.00K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 6 month | Income (Loss) from Equity Method Investments 9 month | Income (Loss) from Equity Method Investments 12 month | Income (Loss) from Equity Method Investments 165 month |
|---|---|---|---|---|---|
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-10 | -$10.00K derived: sum of 2 quarters · filed 2016-05-10 | -$63.00K derived: sum of 3 quarters · filed 2016-05-10 | -$130.00K derived: sum of 4 quarters · filed 2016-05-10 | |
| 2014-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$63.00K derived: sum of 2 quarters · filed 2016-03-15 | -$130.00K derived: sum of 3 quarters · filed 2016-03-15 | -$400.00K 10-K · filed 2016-03-15 | |
| 2014-09-30 | -$53.00K 10-Q · filed 2015-11-09 | -$120.00K derived: sum of 2 quarters · filed 2015-11-09 | -$390.00K 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | -$67.00K 10-Q · filed 2015-08-10 | -$337.00K 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | -$270.00K 10-Q · filed 2015-05-11 | -$270.00K 10-Q · filed 2014-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |